PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
19.44
+0.14 (0.73%)
Sep 16, 2026, 4:00 PM EDT - Market closed
PROCEPT BioRobotics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 337.34 | 308.05 | 224.5 | 136.19 | 75.01 | 34.47 | |
Revenue Growth | 22.69% | 37.22% | 64.84% | 81.55% | 117.60% | 346.72% |
Cost of Revenue | 123.6 | 111.83 | 87.4 | 65.14 | 37.93 | 18.61 |
Gross Profit | 213.75 | 196.23 | 137.1 | 71.05 | 37.09 | 15.87 |
Selling, General & Admin | 252.07 | 228.81 | 171.42 | 131.77 | 88.83 | 51.04 |
Research & Development | 78.81 | 71.28 | 62.3 | 48.45 | 28.98 | 18.99 |
Operating Expenses | 330.88 | 300.09 | 233.71 | 180.22 | 117.81 | 70.03 |
Operating Income | -117.13 | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 |
Interest Expense | -3.47 | -3.59 | -4.18 | -4 | -5.18 | -5.81 |
Interest & Investment Income | 8.26 | 12.22 | 10.9 | 7.55 | 2.5 | 0.08 |
Other Non Operating Income (Expenses) | -0.16 | -0.16 | -1.14 | -0.2 | -0.49 | 0.05 |
EBT Excluding Unusual Items | -112.5 | -95.38 | -91.05 | -105.82 | -83.9 | -59.85 |
Other Unusual Items | 2.9 | - | - | - | -3.26 | - |
Pretax Income | -109.6 | -95.38 | -91.05 | -105.82 | -87.15 | -59.85 |
Income Tax Expense | 0.15 | 0.19 | 0.37 | 0.08 | - | - |
Net Income | -109.76 | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 |
Net Income to Common | -109.76 | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 56 | 56 | 52 | 47 | 44 | 16 |
Shares Outstanding (Diluted) | 56 | 56 | 52 | 47 | 44 | 16 |
Shares Change | 4.24% | 6.56% | 10.31% | 6.43% | 169.42% | 349.90% |
EPS (Basic) | -1.95 | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
EPS (Diluted) | -1.95 | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -84.93 | -58.34 | -103.62 | -133.21 | -83.04 | -57.93 |
Free Cash Flow Per Share | -1.51 | -1.05 | -1.99 | -2.82 | -1.87 | -3.52 |
Gross Margin | 63.36% | 63.70% | 61.07% | 52.17% | 49.44% | 46.02% |
Operating Margin | -34.72% | -33.72% | -43.04% | -80.16% | -107.61% | -157.12% |
Profit Margin | -32.53% | -31.02% | -40.72% | -77.76% | -116.18% | -173.62% |
Free Cash Flow Margin | -25.17% | -18.94% | -46.16% | -97.81% | -110.69% | -168.03% |
EBITDA | -110.08 | -97.47 | -91.38 | -105.36 | -77.88 | -50.84 |
EBITDA Margin | -32.63% | -31.64% | -40.70% | -77.36% | -103.82% | -147.48% |
D&A For EBITDA | 7.05 | 6.39 | 5.23 | 3.81 | 2.84 | 3.32 |
EBIT | -117.13 | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 |
EBIT Margin | -34.72% | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% |
Advertising Expenses | - | 0.6 | 0.5 | 0.3 | 0.1 | 0.1 |